FHD-286 is a BRG1/BRM ATPase inhibitor, which can be used in the study of BAF-related diseases. Fdd-286 is also the first SMARCA2/SMARCA4 dual inhibitor. It can be used in the study of metastatic melanoma and advanced hematologic tumors.
Molecular Weight:
562.66
Purity:
>99.0%
CAS Number:
[2671128-05-3]
Formula:
C24H30N6O6S2
Target:
Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted